Oticon: Difference between revisions
Rockstone35 (talk | contribs) rm claim that's actually an advertistement |
|||
(46 intermediate revisions by 31 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Danish hearing aid manufacturer}} |
|||
{{Refimprove|date=December 2006}}{{Infobox company |
|||
{{Use dmy dates|date=October 2021}} |
|||
{{Infobox company |
|||
| name = Oticon |
| name = Oticon |
||
| logo = Oticon logo ny 0.jpg |
|||
| founded = 1904 |
| founded = 1904 |
||
| founder = Hans Demant |
| founder = Hans Demant |
||
Line 7: | Line 10: | ||
| products = [[Hearing aids]] |
| products = [[Hearing aids]] |
||
| num_employees = 3000+ |
| num_employees = 3000+ |
||
| parent = William Demant Holding Group |
| parent = [[William Demant]] Holding Group |
||
| slogan = People first |
|||
}} |
}} |
||
'''Oticon''' is |
'''Oticon''' is a [[hearing aid]] manufacturer based in [[Copenhagen]], Denmark. The company is a subsidiary of the [[William Demant|Demant Group]]. It was founded in 1904 by Hans Demant, whose wife was [[hearing impairment|hearing impaired]]. The company claims to be the world's second-largest manufacturer of [[Hearing aid|hearing aids]], and uses a [[management style]] known as "spaghetti organization"<ref>{{Cite web |title=Oticon A/S: Spaghetti Organization and Beyond |url=http://www.icmrindia.org/casestudies/catalogue/Business%20Strategy/BSTR318.htm |access-date=12 September 2012 |publisher=IBS Center for Management Research}}</ref><ref>{{Cite web |title=Case Study: Revolution at Oticon A/S: The Spaghetti Organization (Condensed) |url=http://hbr.org/product/revolution-at-oticon-a-s-the-spaghetti-organizatio/an/IMD083-PDF-ENG |access-date=10 September 2012 |publisher=Harvard Business Review}}</ref> introduced by [[Lars Kolind]]<ref>{{Cite book |last=Peters |first=Tom |url=https://archive.org/details/liberationmanage00pete/page/880 |title=Liberation Management |date=January 1994 |publisher=Ballantine Books |isbn=0-449-90888-7 |location=United States |page=[https://archive.org/details/liberationmanage00pete/page/880 880] |url-access=registration}}</ref><ref>{{Cite web |last=Ewing, Jack |date=6 August 2007 |title=Denmark's Masters of E-Mail Marketing |url=http://www.businessweek.com/stories/2007-08-06/denmarks-masters-of-e-mail-marketingbusinessweek-business-news-stock-market-and-financial-advice |archive-url=https://web.archive.org/web/20120709221600/http://www.businessweek.com/stories/2007-08-06/denmarks-masters-of-e-mail-marketingbusinessweek-business-news-stock-market-and-financial-advice |url-status=dead |archive-date=9 July 2012 |access-date=12 September 2012 |publisher=Bloomberg Businessweek}}</ref><ref>{{Cite book |last=Poulsen |first=Per Thygesen |title=Tænk det utænkelige: Revolutionen i Oticon |publisher=Schultz Erhvervsbøger |year=1993 |isbn=87-569-7920-7 |location=Denmark |page=174}}</ref> under his leadership between 1988 and 1998.<ref>{{Cite book |url=https://books.google.com/books?id=MOwZygAACAAJ |title=Tænk det utænkelige: Revolutionen i Oticon |year=1993 |isbn=9788756979207 |access-date=12 September 2012}}</ref><ref>{{Cite web |title=Think the Unthinkable (in Danish: Tænk det utænkelige!) |url=http://kolindkuren.dk/2008/07/23/t%C3%A6nk-det-ut%C3%A6nkelige/ |access-date=12 September 2012 |publisher=Kolind Kuren}}</ref><ref>{{Cite book |last=Morsing |first=Mette |title=Managing the Unmanageable for a Decade |last2=Eiberg |first2=Kristian |publisher=Oticon A/S |year=1998 |location=Denmark |page=244}}</ref> |
||
Oticon has branches in |
Oticon has branches in several countries, including a production plant in [[Poland]], with more than 3,000 employees worldwide.<ref name="Oticon Employees">{{Cite web |title=Oticon Hearing Aids |url=https://www.apexhearing.co.uk/hearing-aids/ |access-date=6 May 2014 |publisher=Apex Hearing}}</ref> |
||
[[File:Intra aural hearing aid Wellcome L0065955.jpg|thumb|upright|Oticon hearing aid]] |
|||
== Oticon Medical == |
|||
In 2016 Oticon launched a revolutionary new advancement in hearing aid technology, the world's first internet connected hearing aid called the Oticon Opn™, characterizing it as a paradigm shift in hearing aids that combines breakthrough technologies proven to enable people with hearing loss to experience less listening effort and enjoy better speech understanding. |
|||
Oticon Medical is a sister company of Oticon, both being subsidiaries of the Demant Group.<ref>{{Cite web |title=Oticon Medical – A company founded on care |url=https://earcommunity.org/oticon-medical-a-company-founded-on-care/658378/ |access-date=2022-03-24 |website=earcommunity.org}}</ref> Whereas Oticon specialises in hearing aids, Oticon Medical specialises in hearing implants and released its first products in 2009.<ref>{{Cite web |title=Our history |url=https://www.demant.com/about/our-history |access-date=2022-03-24 |website=www.demant.com |language=en}}</ref> The company's Ponto bone conduction implant is now in its fifth generation.<ref>{{Cite web |title=Oticon Medical bone-anchored hearing devices |url=https://www.healthyhearing.com/oticon-medical-hearing-implants |access-date=2022-03-24 |website=Healthy Hearing |language=en-US}}</ref> |
|||
In 2013, Oticon Medical acquired [[Demant|Neurelec]], a French producer of cochlear implants.<ref>{{Cite web |last=Apr 2 |last2=Ear |first2=2013 {{!}} Behind the |last3=Implants |first3=Cochlear |last4=News {{!}} 0 {{!}} |first4=Industry |date=2013-04-02 |title=William Demant Acquires Neurelec, a French Manufacturer of Cochlear Implants |url=https://hearingreview.com/hearing-products/implants-bone-conduction/cochlear-implants/william-demant-acquires-neurelec-a-french-manufacturer-of-cochlear-implants |access-date=2022-03-24 |website=The Hearing Review |language=en-US}}</ref> Using the acquired technology, the company developed its own Neuro cochlear implant system, which received FDA approval in 2021.<ref>{{Cite web |date=2021-06-24 |title=FDA approves Oticon Medical's Neuro cochlear implant system |url=https://www.massdevice.com/fda-approves-oticon-medicals-neuro-cochlear-implant-system/ |access-date=2022-03-24 |website=MassDevice |language=en-US}}</ref> |
|||
Powered by the Velox™ platform, the newest BrainHearing™ solution from Oticon employs an “open sound” approach to manage multiple speech and noise sources, even in complex listening situations. The company says the new OpenSound Navigator™ scans the environment 100 times per second to analyze and balance every sound individually. Environmental sounds are said to be accessible, but not disturbing. |
|||
<ref>http://www.hearingreview.com/2016/04/oticons-new-hearing-aid-takes-open-sound-approach/</ref> |
|||
In April 2022, Demant announced it had agreed to sell Oticon Medical to Australian company [[Cochlear Limited]] for DKK850 million and would exit the hearing implant business.<ref>{{Cite web |last=Ogg |first=Matt |date=2022-04-27 |title=Cochlear to acquire loss-making Oticon Medical for $170 million |url=https://www.businessnewsaustralia.com/articles/cochlear-to-acquire-loss-making-oticon-medical-for--170-million.html |access-date=2022-05-06 |website=Business News Australia}}</ref> |
|||
== Product Lines == |
|||
* Opn |
|||
* Alta2 |
|||
* Nera2 |
|||
* Ria2 |
|||
* Dynamo |
|||
* Sensei |
|||
⚫ | |||
=== Mature product line === |
|||
⚫ | |||
{{Columns-list|2|* Safari |
|||
* Dual |
|||
* Acto |
|||
* Hit |
|||
* Amigo |
|||
* Chili |
|||
* Intiga |
|||
* Ino |
|||
* Epoq |
|||
* Vigo |
|||
* Delta |
|||
* Lexis |
|||
* Syncro |
|||
* Tego |
|||
* Atlas |
|||
* Swift |
|||
* Go |
|||
* Go pro |
|||
* Gaia |
|||
* Safran |
|||
* Sumo |
|||
* Sumo DM}} |
|||
== See also == |
|||
⚫ | |||
* [[William Demant]] |
|||
==External links== |
==External links== |
||
⚫ | |||
* [http://www.oticon.com/ Oticon's official website] |
|||
* [http://www.oticonnhs.co.uk Oticon's official UK site for NHS (Oticon NHS)], which includes information and training resources for NHS hearing care professionals and the general public |
* [http://www.oticon.global/ Oticon's official website] |
||
* [https://web.archive.org/web/20110810175821/http://www.oticonnhs.co.uk/ Oticon's official UK site for NHS (Oticon NHS)], which includes information and training resources for NHS hearing care professionals and the general public |
|||
* [http://www.oticon.com/about/our-group/history/founded-on-care.aspx The history of Oticon] |
|||
⚫ | |||
⚫ | |||
{{Authority control}} |
|||
[[Category:Hearing aid manufacturers]] |
[[Category:Hearing aid manufacturers]] |
||
[[Category:Electronics companies of Denmark]] |
[[Category:Electronics companies of Denmark]] |
||
[[Category: |
[[Category:Medical technology companies of Denmark]] |
||
[[Category:Manufacturing companies established in 1904]] |
[[Category:Manufacturing companies established in 1904]] |
||
[[Category: |
[[Category:Danish companies established in 1904]] |
||
[[Category:Danish brands]] |
[[Category:Danish brands]] |
||
{{-}} |
|||
{{Denmark-company-stub}} |
Revision as of 03:11, 27 October 2023
![]() | |
Gegründet | 1904 |
---|---|
Gründer | Hans Demant |
Hauptsitz | Smørum, Egedal , Dänemark |
Produkte | Hearing aids |
Number of employees | 3000+ |
Parent | William Demant Holding Group |
Oticon is a hearing aid manufacturer based in Copenhagen, Denmark. The company is a subsidiary of the Demant Group. It was founded in 1904 by Hans Demant, whose wife was hearing impaired. The company claims to be the world's second-largest manufacturer of hearing aids, and uses a management style known as "spaghetti organization"[1][2] introduced by Lars Kolind[3][4][5] under his leadership between 1988 and 1998.[6][7][8]
Oticon has branches in several countries, including a production plant in Poland, with more than 3,000 employees worldwide.[9]
![](http://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Intra_aural_hearing_aid_Wellcome_L0065955.jpg/170px-Intra_aural_hearing_aid_Wellcome_L0065955.jpg)
Oticon Medical
Oticon Medical is a sister company of Oticon, both being subsidiaries of the Demant Group.[10] Whereas Oticon specialises in hearing aids, Oticon Medical specialises in hearing implants and released its first products in 2009.[11] The company's Ponto bone conduction implant is now in its fifth generation.[12]
In 2013, Oticon Medical acquired Neurelec, a French producer of cochlear implants.[13] Using the acquired technology, the company developed its own Neuro cochlear implant system, which received FDA approval in 2021.[14]
In April 2022, Demant announced it had agreed to sell Oticon Medical to Australian company Cochlear Limited for DKK850 million and would exit the hearing implant business.[15]
References
- ^ "Oticon A/S: Spaghetti Organization and Beyond". IBS Center for Management Research. Retrieved 12 September 2012.
- ^ "Case Study: Revolution at Oticon A/S: The Spaghetti Organization (Condensed)". Harvard Business Review. Retrieved 10 September 2012.
- ^ Peters, Tom (January 1994). Liberation Management. United States: Ballantine Books. p. 880. ISBN 0-449-90888-7.
- ^ Ewing, Jack (6 August 2007). "Denmark's Masters of E-Mail Marketing". Bloomberg Businessweek. Archived from the original on 9 July 2012. Retrieved 12 September 2012.
- ^ Poulsen, Per Thygesen (1993). Tænk det utænkelige: Revolutionen i Oticon. Denmark: Schultz Erhvervsbøger. p. 174. ISBN 87-569-7920-7.
- ^ Tænk det utænkelige: Revolutionen i Oticon. 1993. ISBN 9788756979207. Retrieved 12 September 2012.
- ^ "Think the Unthinkable (in Danish: Tænk det utænkelige!)". Kolind Kuren. Retrieved 12 September 2012.
- ^ Morsing, Mette; Eiberg, Kristian (1998). Managing the Unmanageable for a Decade. Denmark: Oticon A/S. p. 244.
- ^ "Oticon Hearing Aids". Apex Hearing. Retrieved 6 May 2014.
- ^ "Oticon Medical – A company founded on care". earcommunity.org. Retrieved 24 March 2022.
- ^ "Our history". www.demant.com. Retrieved 24 March 2022.
- ^ "Oticon Medical bone-anchored hearing devices". Healthy Hearing. Retrieved 24 March 2022.
- ^ Apr 2; Ear, 2013 | Behind the; Implants, Cochlear; News | 0 |, Industry (2 April 2013). "William Demant Acquires Neurelec, a French Manufacturer of Cochlear Implants". The Hearing Review. Retrieved 24 March 2022.
{{cite web}}
: CS1 maint: numeric names: authors list (link) - ^ "FDA approves Oticon Medical's Neuro cochlear implant system". MassDevice. 24 June 2021. Retrieved 24 March 2022.
- ^ Ogg, Matt (27 April 2022). "Cochlear to acquire loss-making Oticon Medical for $170 million". Business News Australia. Retrieved 6 May 2022.
External links
- Oticon's official website
- Oticon's official UK site for NHS (Oticon NHS), which includes information and training resources for NHS hearing care professionals and the general public